Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 14

Factors to Consider When Determining Whether Lipotoxicity Solely Causes B-Cell Decompensation in KPT2D [Letter]

Authors Geltser D

Received 27 February 2021

Accepted for publication 2 March 2021

Published 9 March 2021 Volume 2021:14 Pages 1083—1084


Checked for plagiarism Yes

Editor who approved publication: Professor Ming-Hui Zou

Dan Geltser

Imperial College London, School of Medicine, London, UK

Correspondence: Dan Geltser
Imperial College London, School of Medicine, London, UK
Email [email protected]

I read with great interest the paper by Ye et al,1 which identified the significance of raised triglycerides in the treatment of ketosis-prone type 2 diabetes (KPT2D). The study concluded the need to implement lifestyle changes and administration of lipid-lowering medication for paediatric, hyperglycaemic KPT2D patients. As a 5th year medical student, who completed an intercalated BSc focusing on lipidology in diabetes mellitus, I would like to discuss further factors which should be considered when evaluating the conclusion.
View the original paper by Ye and colleagues

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]